Myseum Financials
This page shows Myseum (MYSEW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Myseum has an operating margin of -1211216.3%, meaning the company retains $-1211216 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -1307147.5% the prior year.
Myseum's revenue declined 35.1% year-over-year, from $672 to $436. This contraction results in a growth score of 0/100.
With a current ratio of 6.80, Myseum holds $6.80 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
Myseum generates a -61.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -137.8% the prior year.
Myseum passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Myseum generates $1.04 in operating cash flow (-$4.4M OCF vs -$4.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Myseum generated $436 in revenue in fiscal year 2024. This represents a decrease of 35.1% from the prior year.
Myseum's EBITDA was -$5.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 39.9% from the prior year.
Myseum reported -$4.2M in net income in fiscal year 2024. This represents an increase of 49.6% from the prior year.
Myseum earned $-1.43 per diluted share (EPS) in fiscal year 2024. This represents an increase of 65.5% from the prior year.
Cash & Balance Sheet
Myseum held $1.2M in cash against $0 in long-term debt as of fiscal year 2024.
Myseum had 3M shares outstanding in fiscal year 2024. This represents an increase of 47.8% from the prior year.
Margins & Returns
Myseum's operating margin was -1211216.3% in fiscal year 2024, reflecting core business profitability. This is up 95931.2 percentage points from the prior year.
Myseum's net profit margin was -972284.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 278455.2 percentage points from the prior year.
Myseum's ROE was -61.6% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 76.2 percentage points from the prior year.
Capital Allocation
Myseum invested $858K in research and development in fiscal year 2024. This represents a decrease of 36.5% from the prior year.
MYSEW Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $328+320.5% | $78-6.0% | $83-9.8% | $92+48.4% | $62-58.9% | $151+15.3% | $131-23.4% | $171 |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $5K-16.7% | $6K-82.5% | $34K-90.6% | $363K+60.8% | $226K-3.4% | $234K-33.4% | $351K |
| SG&A Expenses | $230K-4.2% | $240K+23.9% | $194K-37.0% | $307K+95.5% | $157K-33.3% | $235K-3.4% | $244K+0.9% | $242K |
| Operating Income | -$1.3M+9.0% | -$1.4M+15.3% | -$1.7M-49.3% | -$1.1M+10.2% | -$1.2M+2.3% | -$1.3M+23.8% | -$1.7M-11.4% | -$1.5M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$1.2M+1.3% | -$1.2M+17.4% | -$1.5M-74.1% | -$846K+33.5% | -$1.3M-29.3% | -$983K+13.6% | -$1.1M+16.0% | -$1.4M |
| EPS (Diluted) | $-0.28+3.4% | $-0.29+19.4% | $-0.36 | N/A | $-0.42-27.3% | $-0.33+19.5% | $-0.41 | N/A |
MYSEW Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.8M-9.2% | $7.4M-12.4% | $8.5M+58.4% | $5.4M+11.5% | $4.8M-11.4% | $5.4M-15.3% | $6.4M-1.3% | $6.5M |
| Current Assets | $5.1M-12.2% | $5.8M-19.7% | $7.2M+68.0% | $4.3M-9.9% | $4.8M-11.2% | $5.4M-15.2% | $6.3M-0.9% | $6.4M |
| Cash & Equivalents | $458K+12.2% | $408K-67.8% | $1.3M+5.7% | $1.2M+89.2% | $632K+7.7% | $588K+135.0% | $250K-73.8% | $953K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $224+1.8% | $220-10.9% | $247+19.3% | $207+5.6% | $196+2.1% | $192-4.0% | $200+9.3% | $183 |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | -$1.6M+10.9% | -$1.8M+0.4% | -$1.8M-17.6% | -$1.5M+33.4% | -$2.3M-658.5% | $406K-9.7% | $449K+10.4% | $407K |
| Current Liabilities | $888K+37.8% | $644K-7.9% | $699K+11.0% | $630K+18.7% | $531K+31.0% | $406K-9.7% | $449K+10.4% | $407K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $8.3M-9.5% | $9.2M-10.4% | $10.3M+49.5% | $6.9M-2.9% | $7.1M+15.7% | $6.1M-10.6% | $6.8M+12.2% | $6.1M |
| Retained Earnings | -$56.3M-2.2% | -$55.1M-2.3% | -$53.8M-2.8% | -$52.4M-1.6% | -$51.5M-2.5% | -$50.3M-2.0% | -$49.3M-2.4% | -$48.1M |
MYSEW Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$904K+25.0% | -$1.2M+14.2% | -$1.4M-59.5% | -$881K+7.9% | -$957K+10.8% | -$1.1M+27.4% | -$1.5M-7.8% | -$1.4M |
| Capital Expenditures | $0 | N/A | N/A | N/A | N/A | N/A | N/A | $0 |
| Free Cash Flow | -$904K | N/A | N/A | N/A | N/A | N/A | N/A | -$1.4M |
| Investing Cash Flow | $944K+153.8% | $372K+112.8% | -$2.9M-400.4% | $967K+30.4% | $742K-36.9% | $1.2M+281.4% | -$648K-139.0% | $1.7M |
| Financing Cash Flow | $10K+141.6% | -$24K-100.5% | $4.4M+815.8% | $478K+83.9% | $260K+10.2% | $236K-83.4% | $1.4M | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MYSEW Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -390427.1%+1413198.5pp | -1803625.6%+196911.7pp | -2000537.4%-791627.6pp | -1208909.8%+788161.2pp | -1997071.0%-1157929.9pp | -839141.1%+430644.4pp | -1269785.5%-396917.7pp | -872867.8% |
| Net Margin | -366304.0%+1193788.4pp | -1560092.3%+214842.6pp | -1774934.9%-855043.6pp | -919891.3%+1131400.6pp | -2051291.9%-1400135.0pp | -651156.9%+217401.8pp | -868558.8%-76777.5pp | -791781.3% |
| Return on Equity | -14.4%-1.2pp | -13.2%+1.1pp | -14.3%-2.0pp | -12.3%+5.7pp | -18.0%-1.9pp | -16.1%+0.6pp | -16.6%+5.6pp | -22.2% |
| Return on Assets | -17.8%-1.4pp | -16.3%+1.0pp | -17.3%-1.6pp | -15.8%+10.7pp | -26.4%-8.3pp | -18.1%-0.4pp | -17.7%+3.1pp | -20.8% |
| Current Ratio | 5.72-3.3 | 8.98-1.3 | 10.30+3.5 | 6.80-2.2 | 8.96-4.2 | 13.20-0.9 | 14.07-1.6 | 15.68 |
| Debt-to-Equity | -0.190.0 | -0.19-0.0 | -0.17+0.0 | -0.22+0.1 | -0.32-0.4 | 0.070.0 | 0.070.0 | 0.07 |
| FCF Margin | -275748.8% | N/A | N/A | N/A | N/A | N/A | N/A | -801033.3% |
Frequently Asked Questions
What is Myseum's annual revenue?
Myseum (MYSEW) reported $436 in total revenue for fiscal year 2024. This represents a -35.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Myseum's revenue growing?
Myseum (MYSEW) revenue declined by 35.1% year-over-year, from $672 to $436 in fiscal year 2024.
Is Myseum profitable?
No, Myseum (MYSEW) reported a net income of -$4.2M in fiscal year 2024, with a net profit margin of -972284.4%.
What is Myseum's earnings per share (EPS)?
Myseum (MYSEW) reported diluted earnings per share of $-1.43 for fiscal year 2024. This represents a 65.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Myseum's EBITDA?
Myseum (MYSEW) had EBITDA of -$5.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Myseum's operating margin?
Myseum (MYSEW) had an operating margin of -1211216.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Myseum's net profit margin?
Myseum (MYSEW) had a net profit margin of -972284.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Myseum's return on equity (ROE)?
Myseum (MYSEW) has a return on equity of -61.6% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Myseum's operating cash flow?
Myseum (MYSEW) generated -$4.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Myseum's total assets?
Myseum (MYSEW) had $5.4M in total assets as of fiscal year 2024, including both current and long-term assets.
How much does Myseum spend on research and development?
Myseum (MYSEW) invested $858K in research and development during fiscal year 2024.
How many shares does Myseum have outstanding?
Myseum (MYSEW) had 3M shares outstanding as of fiscal year 2024.
What is Myseum's current ratio?
Myseum (MYSEW) had a current ratio of 6.80 as of fiscal year 2024, which is generally considered healthy.
What is Myseum's debt-to-equity ratio?
Myseum (MYSEW) had a debt-to-equity ratio of -0.22 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Myseum's return on assets (ROA)?
Myseum (MYSEW) had a return on assets of -78.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Myseum's cash runway?
Based on fiscal year 2024 data, Myseum (MYSEW) had $1.2M in cash against an annual operating cash burn of $4.4M. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Myseum's Piotroski F-Score?
Myseum (MYSEW) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Myseum's earnings high quality?
Myseum (MYSEW) has an earnings quality ratio of 1.04x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Myseum?
Myseum (MYSEW) scores 25 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.